ST2 is a member of the interleukin 1 receptor family and may be a biomarker of cardiac stress. ST2 signals the presence and severity of adverse cardiac remodeling and tissue fibrosis, which occurs during myocardial infarction or acute coronary syndrome. It binds IL-33 and soluble ST2 may function as a decoy receptor
Swiss-Prot Accession Number: Q01638
A leading global drug discovery and development laboratory, IQVIA Laboratories (the laboratory business of IQVIA) provides customers with a comprehensive assemblage of solutions encompassing central laboratory and specialty biomarker services including genomics, immunoassays, flow cytometry, anatomic pathology, precision medicine assays, vaccine assays, ADME and bioanalytical along with extensive offerings in antibody drug discovery, biomarker discovery, and decentralized clinical trial lab solutions.
Learn more at labs.iqvia.com
Copyright 2025 Rules-Based Medicine. All rights reserved. RBM does not sell your personal information.